Tele-rehabilitation in COVID-19 survivors (TERCOV): An investigator-initiated, prospective, multi-center, real-world study.

Autor: Wen G; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.; National Clinical Research Center for Respiratory Disease, Beijing, China.; National Center for Respiratory Medicine, Beijing, China.; Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Yunnan Province, Kunming City, China., Yang L; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.; National Clinical Research Center for Respiratory Disease, Beijing, China.; National Center for Respiratory Medicine, Beijing, China.; Capital Medical University, Beijing, China.; Fangzhuang Community Health Service Center, Capital Medical University, Beijing, China., Qumu S; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.; National Clinical Research Center for Respiratory Disease, Beijing, China.; National Center for Respiratory Medicine, Beijing, China., Situ X; Department of Rehabilitation Medicine, China-Japan Friendship Hospital, Beijing, China.; Zhongshan Orthopedic Hospital, Dalian, Liaoning, China., Lei J; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.; National Clinical Research Center for Respiratory Disease, Beijing, China.; National Center for Respiratory Medicine, Beijing, China.; Data and Project Management Unit, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China., Yu B; Department of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Wuhan, China., Liu B; Department of Pulmonary and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.; Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China., Liang Y; Department of Pulmonary and Critical Care Medicine, Wuhan Pulmonary Hospital, Wuhan, China., He J; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.; National Clinical Research Center for Respiratory Disease, Beijing, China.; National Center for Respiratory Medicine, Beijing, China.; Capital Medical University, Beijing, China., Wang R; Department of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Wuhan, China., Ni F; Department of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Wuhan, China., Wu C; Department of Pulmonary and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China., Zheng X; Department of Pulmonary and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China., Yin Y; Department of Pulmonary and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China., Lin J; Department of Pulmonary and Critical Care Medicine, Wuhan Pulmonary Hospital, Wuhan, China., Bao J; Department of Pulmonary and Critical Care Medicine, Wuhan Pulmonary Hospital, Wuhan, China., Yang T; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.; National Clinical Research Center for Respiratory Disease, Beijing, China.; National Center for Respiratory Medicine, Beijing, China., Hu Y; Department of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Wuhan, China., Cheng Z; Department of Pulmonary and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.; Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China., Guo G; Department of Pulmonary and Critical Care Medicine, Wuhan Pulmonary Hospital, Wuhan, China.
Jazyk: angličtina
Zdroj: Physiotherapy research international : the journal for researchers and clinicians in physical therapy [Physiother Res Int] 2024 Oct; Vol. 29 (4), pp. e2137.
DOI: 10.1002/pri.2137
Abstrakt: Introduction: Center-based rehabilitation is limited by COVID-19 infectivity and social distancing policy. We hypothesized that discharged patients benefit from 8-week home-based tele-rehabilitation (tele-PR) using mobile phones and low-cost instruments.
Methods: The TERCOV (Tele-rehabilitation in COVID-19 survivors) is an investigator-initiated, prospective, multi-center, real-world study. After proper assessment, 186 discharge patients received tele-PR by smartphone, including breathing exercise, respiratory muscle training, aerobic exercise, and resistance training. Physicians, physiotherapists, and nurses provided guidance through smartphone applications. The primary outcome was six-minute walk distance (6MWD). The secondary outcomes included hand grip, short physical performance battery, maximal inspiratory pressure, maximal expiratory pressure, self-rating anxiety/depression scale (SAS/SDS), 36-item short-form health survey (SF-36) and international physical activity questionnaire.
Results: Dyspnea subgroups were more functionally impaired. After tele-PR, improvements were observed in exercise capacity(∆6MWD: 16.80 m, 95% CI 1.18-32.42, p < 0.0001), limb muscle function (∆SPPB 0.25 points, 95% CI 0.05-0.46), respiratory muscle strength (∆MIP 16.50 cm H2O, 95% CI 9.22-23.78, p < 0.0001; ∆MEP: 12.09 cm H2O, 95% CI 3.48-20.70, p = 0.0002), health-related quality of life (∆SF-36 49.85, 95% CI: 21.01-78.69, p < 0.0001), physical activity(∆HEPA 13.01%, p = 0.0029). Anxiety reduced in patients with mMRC ≥ 2 (∆SAS = -4.19 points, CI -8.16 to -0.22, p = 0.03). Greater change was seen in dyspnea patients.
Implications on Physiotherapy Practice: Supervised/semi-supervised tele-PR is a promising option during the pandemic. Patients with Dyspnea benefit more.
(© 2024 John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz: